About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Prkar2b
protein kinase, cAMP dependent regulatory, type II beta
MGI:97760
33 phenotypes from 3 alleles in 10 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Prkar2btm1Gsm/Prkar2btm1Gsm
B6.129-Prkar2btm1Gsm 		abnormal food intake J:72414
decreased body weight J:72414
decreased circulating cholesterol level J:72414
decreased circulating insulin level J:72414
decreased circulating LDL cholesterol level J:72414
decreased circulating leptin level J:72414
decreased circulating VLDL cholesterol level J:72414
decreased liver triglyceride level J:72414
decreased susceptibility to diet-induced hepatic steatosis J:72414
decreased susceptibility to diet-induced obesity J:72414
normal homeostasis/metabolism phenotype J:72414
improved glucose tolerance J:72414
Prkar2btm1Gsm/Prkar2btm1Gsm
involves: 129X1/SvJ * C57BL/6 		enhanced behavioral response to addictive substance J:47453
impaired coordination J:47453
Prkar2btm1Gsm/Prkar2btm1Gsm
Not Specified 		abnormal energy expenditure J:34751
decreased body weight J:34751
decreased circulating leptin level J:34751
decreased susceptibility to diet-induced hepatic steatosis J:34751
decreased susceptibility to diet-induced obesity J:34751
decreased triglyceride level J:34751
decreased white adipose tissue amount J:34751
normal homeostasis/metabolism phenotype J:34751
increased body temperature J:34751
polyphagia J:34751
Prkar2btm2Gsm/Prkar2b+
involves: C57BL/6 		decreased circulating leptin level J:131039
decreased percent body fat/body weight J:131039
polyphagia J:131039
Prkar2btm2Gsm/Prkar2btm2Gsm
involves: C57BL/6 		decreased percent body fat/body weight J:131039
increased locomotor activity J:131039
Prkar2btm3Gsm/Prkar2btm2Gsm
Drd1tm1(cre)Rpa/Drd1+
involves: C57BL/6 		normal adipose tissue phenotype J:196157
normal growth/size/body region phenotype J:196157
normal homeostasis/metabolism phenotype J:196157
hyperactivity J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Slc32a1tm2(cre)Lowl/Slc32a1+
involves: 129S6/SvEvTac * C57BL/6 		normal adipose tissue phenotype J:196157
normal behavior/neurological phenotype J:196157
normal growth/size/body region phenotype J:196157
normal homeostasis/metabolism phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Drd2-cre)ER44Gsat/0
involves: C57BL/6 * FVB/N 		normal behavior/neurological phenotype J:196157
decreased body weight J:196157
decreased circulating leptin level J:196157
decreased total body fat amount J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Fabp4-cre)1Rev/0
involves: C57BL/6 		decreased body weight J:196157
decreased circulating leptin level J:196157
decreased gonadal fat pad weight J:196157
decreased total body fat amount J:196157
increased locomotor activity J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Ins2-cre)25Mgn/0
involves: C57BL/6 * DBA 		normal adipose tissue phenotype J:196157
normal behavior/neurological phenotype J:196157
normal growth/size/body region phenotype J:196157
normal homeostasis/metabolism phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Nes-cre)1Kln/0
involves: C57BL/6 * SJL 		normal adipose tissue phenotype J:196157
normal behavior/neurological phenotype J:196157
normal growth/size/body region phenotype J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Ppp1r1b-cre)1Meeh/0
involves: C57BL/6 		normal behavior/neurological phenotype J:196157
decreased circulating leptin level J:196157
decreased lean body mass J:196157
Prkar2btm3Gsm/Prkar2btm2Gsm
Tg(Syn1-cre)671Jxm/0
involves: C57BL/6 * CBA 		normal adipose tissue phenotype J:196157
normal behavior/neurological phenotype J:196157
normal growth/size/body region phenotype J:196157
Prkar2btm3Gsm/Prkar2btm3Gsm
B6.Cg-Prkar2btm3Gsm 		abnormal energy expenditure J:196157
abnormal food intake J:196157
decreased body weight J:196157
decreased circulating cholesterol level J:196157
decreased circulating insulin level J:196157
decreased circulating LDL cholesterol level J:196157
decreased circulating leptin level J:196157
decreased circulating VLDL cholesterol level J:196157
decreased liver triglyceride level J:196157
decreased percent body fat/body weight J:196157
decreased susceptibility to diet-induced obesity J:196157
decreased susceptibility to hepatic steatosis J:196157
decreased triglyceride level J:196157
decreased white adipose tissue amount J:196157
hyperactivity J:196157
improved glucose tolerance J:196157
increased energy expenditure J:196157
increased respiratory quotient J:196157
Prkar2btm3Gsm/Prkar2btm3Gsm
B6.Cg-Prkar2btm3Gsm 		increased body weight J:196157
increased total body fat amount J:196157
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory